- Home
- ZLAB vs PRGO Comparison
ZLAB vs PRGO Comparison
Compare ZLAB & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZLAB | PRGO |
|---|---|---|
| Founded | 2013 | 1887 |
| Country | China | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2017 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ZLAB | PRGO |
|---|---|---|
| Price | $19.20 | $13.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $51.52 | $20.33 |
| AVG Volume (30 Days) | 600.7K | ★ 2.1M |
| Earning Date | 05-29-2026 | 05-29-2026 |
| Dividend Yield | N/A | ★ 8.18% |
| EPS Growth | ★ 38.46 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $460,156,000.00 | $800,000.00 |
| Revenue This Year | $19.06 | N/A |
| Revenue Next Year | $18.58 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 15.33 | N/A |
| 52 Week Low | $15.96 | $12.17 |
| 52 Week High | $44.34 | $30.93 |
Technical Indicators
Market Signals| Indicator | ZLAB | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 52.53 | 33.49 |
| Support Level | $17.00 | $12.45 |
| Resistance Level | $19.70 | $15.08 |
| Average True Range (ATR) | 0.72 | 0.55 |
| MACD | 0.04 | -0.10 |
| Stochastic Oscillator | 59.77 | 26.16 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.